SOURCE: TalkPoint

TalkPoint

August 17, 2010 10:12 ET

FDAAdvisoryCommittee.com to Webcast Review of Cymbalta® as Treatment for Chronic Pain

Meeting to Discuss New Use for Established Antidepressant Drug Will Be Streamed Live and Archived for Six Months

NEW YORK, NY--(Marketwire - August 17, 2010) -  FDAAdvisoryCommittee.com (FDAAC.com), a provider of live video webcasts of Food and Drug Administration (FDA) Advisory Committee meetings, today announced that it will webcast the meeting of the Anesthetic and Life Support Drugs Advisory Committee as it discusses Cymbalta® as treatment of chronic pain. The meeting is scheduled to occur on August 19, 2010 from 8:00 a.m. to 4:30 p.m. ET.

On the heels of recently completed studies on pain due to osteoarthritis and chronic lower back pain, Eli Lilly and Company has submitted a supplemental New Drug Application for Cymbalta (duloxetine HCI) as it relates to the treatment of chronic pain. Cymbalta is currently approved in the United States for the treatment of depression and anxiety, and for the management of diabetic peripheral neuropathic pain and fibromyalgia.

Audience members, including biotech equity analysts, pharmaceutical employees, and journalists, will be able to watch from anywhere in the world as the Committee reviews the available safety and efficacy data for Cymbalta. FDAAC.com will webcast the meeting live and on location from the Bethesda Marriott in Bethesda, Maryland.

FDAAC.com is committed to delivering the highest quality of video and experience. By utilizing h.264 encoding in conjunction with Flash Media, FDAAC.com's webcasts deliver a near instantaneous stream. These high-quality streams can be accessed from anywhere around the globe and are archived for six months after the live event for unlimited review.

FDAAC.com's webcasts are powered by TalkPoint, a provider of Web-based audio and video Webcasting solutions and services. With over a decade of experience, TalkPoint has developed the most robust, scalable, interactive webcasting platform in the industry. TalkPoint's easy-to-use applications incorporate audio, video, slides, and other interactive elements to deliver high-impact webcasts cost-effectively.

To join the webcast on August 19, at 8 a.m. ET register at
http://fdaac.com

About FDAAdvisoryCommittee.com
FDAAC.com provides live video webcasts of FDA Advisory Committee meetings captured on location. These meetings cover an array of topics related to medicinal health including OTC, prescription and treatment devices. Very often meetings will result in rulings on clinical trials, final approval and bans of medications and treatment options. TalkPoint is the exclusive webcast provider for FDAAdvisoryCommittee.com.

For more information on FDAAC.com, go to www.fdaac.com

Contact Information

  • Media Contacts:
    Richard Taber
    FDAAdvisoryCommittee.com
    Tel: (800) 627-8171
    Email Contact

    Jeff Horan
    LVA Communications
    Tel: (860) 739-5598
    Email: Email Contact